Table 3.
Prevalence of malaria infection, anemia, and fever after round 4 and round 5 of SMC in Dangassa.
| Outcome | ||||||
|---|---|---|---|---|---|---|
| 5–9 years |
10–14 years |
|||||
| Control n(%) |
SMC n(%) |
p | Control n(%) |
SMC n(%) |
p | |
| Round 4 | ||||||
| Malaria infection | 17(20.5) | 8(10.7) | 0.091 | 14(22.6) | 12(17.9) | 0.509 |
| Anemia | 43(49.3) | 21(25.9) | 0.002 | 16(25.0) | 7(9.7) | 0.018 |
| Gametocyte carriage | 2(2.4) | 2(2.7) | 0.918 | 3(4.8) | 2(3.0) | 0.586 |
| Fever | 7(8.1) | 10(12.4) | 0.356 | 2(3.1) | 5(6.9) | 0.314 |
| Round 5 | ||||||
| Malaria infection | 24(29.6) | 6(8.0) | 0.001 | 23(39.7) | 11(15.7) | 0.002 |
| Anemia | 31(38.3) | 21(28.0) | 0.174 | 18(31.0) | 18(25.7) | 0.505 |
| Gametocyte carriage | 2(2.5) | 3(4.0) | 0.588 | 2(3.5) | 1(1.4) | 0.452 |
| Fever | 4(4.7) | 4(5.1) | 0.915 | 7(10.9) | 5(6.7) | 0.372 |